Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fola-B Complex is a pharmaceutical-grade vitamin supplement manufactured by Trifluent Pharma. It is a combination product typically consisting of folic acid (Vitamin B9) and essential B-complex vitamins, including pyridoxine (Vitamin B6) and cyanocobalamin (Vitamin B12). The supplement is indicated for the management of nutritional deficiencies, the prevention of megaloblastic anemia, and the reduction of elevated homocysteine levels, which is a known risk factor for cardiovascular disease. Folic acid is converted into tetrahydrofolate, which acts as a one-carbon donor in the synthesis of purines and pyrimidines, while B12 and B6 serve as vital cofactors in amino acid metabolism and neurological maintenance. As an established product with assigned NDC codes, Fola-B Complex is marketed for clinical use rather than being a clinical-stage pipeline candidate.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fola-B Complex.